Beacon Investment Advisory Services’s PDS Biotechnology PDSB Stock Holding History

Beacon Investment Advisory Services’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4	Hold	5	–	–	﹤0.01%	799
2026 Q2	$5	Hold	5	–	–	﹤0.01%	809
2026 Q1	$4	Buy	+5	New	+$4	﹤0.01%	782

Other funds holding PDSB

IWA

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

TWP

Tempus Wealth Planning Irvine, California $522M AUM 17.46% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Beacon Investment Advisory Services's PDSB Position: Q3 2026 in Review

Beacon Investment Advisory Services held its PDS Biotechnology (PDSB) position steady in Q3 2026 at 5 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #799.

Beacon Investment Advisory Services first reported a position in PDSB in Q1 2026 and has held it in 3 quarters since. The position peaked at $5 in Q2 2026. 5 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

Beacon Investment Advisory Services held 5 shares of PDS Biotechnology worth $4 as of Q3 2026.
Beacon Investment Advisory Services left its PDS Biotechnology share count unchanged in Q3 2026.
PDS Biotechnology made up ﹤0.01% of Beacon Investment Advisory Services's portfolio in Q3 2026, its #799 holding.
Beacon Investment Advisory Services first reported a position in PDS Biotechnology in Q1 2026 and has held it in 3 quarters since.
Beacon Investment Advisory Services's PDS Biotechnology position peaked at $5 in Q2 2026.
5 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.